Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemiaNathaniel D. Anderson, Sara Ghorashian, Martin Pulé et al.|Nature Medicine|2023Cited by 80
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAREvangelia Kokalaki, Martin Pulé|Molecular Therapy|2023Cited by 31
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Martin Pulé|Molecular Therapy — Methods & Clinical Development|2023Cited by 15
Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacyCallum McKenzie, Martin Pulé|Molecular Therapy — Nucleic Acids|2023Cited by 11
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine ReceptorsMatteo Righi, Martin Pulé|Cancer Immunology Research|2023Cited by 10